Using the Edwards MITRIS RESILIA valve in Asian patients
Part of Heart & circulation clinical trials.
This study looks at how well a new mitral valve (the Edwards MITRIS RESILIA) works in people of Asian descent. It aims to see if this valve is safe and effective for patients who need mitral valve replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You need surgery to replace your mitral valve (the valve between the left chambers of your heart).
- You must be willing to sign a consent form and follow the study's visit schedule.
- You should not have a life expectancy of less than one year for reasons other than heart disease.
- Your surgical risk (chance of dying during surgery) must be less than 10%, as assessed by standard scores or your surgeon.
- You must not have severe kidney disease (eGFR below 30) or be having surgery for an active heart infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a replacement valve (called MITRIS) for people whose own mitral valve or a previous artificial valve is not working well. The goal is to see how well the valve works over time after it is implanted.
This study is a registry (a way to track real-world outcomes) for people with mitral valve disease who receive a mitral valve procedure. It helps doctors understand how well these procedures work and what complications happen in patients like you.
This study collects information from patients in the Asia-Pacific region who have had or plan to have a procedure to replace a failing mitral or tricuspid valve with a new valve placed inside the old one (called valve-in-valve) or inside a ring that was used in a previous repair (valve-in-ring). The goal is to learn more about how well these procedures work and how they can be improved.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
This study looks at how well a new valve works when placed inside a previous mitral or tricuspid valve repair or replacement. It may help people who need another procedure on these heart valves.
This trial tests a new device called the SATURN system, which places a new mitral valve without open-heart surgery. It is for people aged 65 and older with severe mitral regurgitation who are at high risk for surgery.
Hear when a new Mitral Valve Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.